A 40-kDa protein antigen from Corynebacterium pseudotuberculosis has been identified by application of a strategy that employs locally derived antibody-secreting cells (ASC). ASC probes generated by culture of ASC obtained from the lymph node draining the site of infection showed a specificity restricted to a 40-kDa antigen.
One of the major difficulties limiting the development of new defined-subunit vaccines is the identification or selection of protective antigens. Bacteria and parasites present the researcher and the host with a complex array of immunogenic molecules. To date, candidate vaccine antigens have been selected on the basis of their known or putative role in infection, e.g., bacterial toxins or essential enzymes of parasites such as glutathione-S-transferase (19) , or on the basis of their identification with antibodies from immune sera. However, the complexity of the immune response to the pathogen is usually indicated by the very diverse antibody response in immune sera, and reliance on selection of molecules judged to be immunodominant on the basis of their reactivity with serum antibody has not always been successful in identifying protective antigens. For example, immunodominant membrane proteins of Mycoplasma hyopneumoniae (21) and Plasmodium falciparum (20) have not proved to be protective.
Caseous lymphadenitis (CLA) is a common and economically important disease of sheep and goats, caused by infection with Corynebacterium pseudotuberculosis. The disease is characterized by the formation of encapsulated necrotic or caseous lesions that in sheep are located primarily in peripheral lymph nodes and the lungs. C. pseudotuberculosis is a facultative intracellular pathogen that multiplies within macrophages. It is readily phagocytosed by nonimmune macrophages, and following phagocytosis with ovine (11) and caprine (22) macrophages, phagosomes fuse with lysosomes but bacteria continue to multiply within phagolysosomes, leading to cell death, release of bacteria, and ultimately a necrotic lesion. The response of the host is to contain the pyogranuloma by the formation of a strong collagen capsule (15) . The immune response to natural infection has been shown to include a strong humoral component, with circulating antibodies detected to a large number of antigens (9) . Cell-mediated immunity has also been implicated in control of CLA lesion * Corresponding author. Phone: 61 3 344 7348. Fax: 61 3 347 4083. development, with lymphocytes observed inside the collagen capsule in intimate contact with necrotic tissue (23) . The intracapsular lymphocytes have a defined architecture of three layers, with high proportions of CD8 and of -yi T-cell subpopulations being striking features of the observed cellular response to C. pseudotuberculosis infection.
Two major virulence determinants of C. pseudotuberculosis are currently recognized-a potent phospholipase D (PLD) exotoxin (14) of 31 kDa, believed important in facilitating spread of the disease, and a toxic lipid associated with the cell wall (4, 12) . Production of both of these factors by strains of C. pseudotuberculosis has been correlated with virulence (17) .
Vaccination against CLA in sheep has been attempted with a variety of antigens, with variable success. Jolly (14) showed the involvement of toxoid in protection. More recently, purified toxoid has been shown to provide a similar level of protection to a complex array of culture supernatant-derived antigens (5) . Comparison of protection against CLA achieved with whole-culture, culture supernatant, and whole-cell antigens has led others (2, 3) to conclude that cell-associated antigens were required as well as toxoid for optimal protection. The ability of cell-associated antigens to protect lambs against CLA has been recently confirmed by using bacterial cell walls with muramyl dipeptide as an adjuvant (1). Hodgson et al. (13) have shown that infection of sheep with an avirulent toxinminus strain of C. pseudotuberculosis with a deletion of the PLD toxin gene induces strong immunity to CLA, providing incontrovertible evidence that antigens other than PLD contribute to protection.
Despite many studies demonstrating the involvement of an antigen(s) other than toxin in protection, no such antigen has been described. We antigen was identified as a major cell protein of 28 kDa on SDS-polyacrylamide gel electrophoresis (PAGE) of whole cells (Fig. 2a, lane 1) that gave a background reaction on immunoblots. Other minor bands did not increase in intensity from days 2 to 7 of infection (Fig. la, panel i) . Infections of C. pseudotuberculosis that were allowed to proceed for 14 days stimulated antibodies to a wide range of antigens, the immunoblot patterns of sera becoming more complex from day 7 onwards, as the infection progressed. ASC probes prepared from lymph nodes taken from sheep killed at day 7 of infection showed little reactivity on immunoblots (Fig. lb, panel i) . The background band at 28 kDa observed on immunoblots with preinfection sera was also seen with ASC probes prepared from lymph nodes draining infected sites of sheep killed at day 7 (Fig. lb, panel i) and from lymph nodes draining uninfected sites (Fig. lb, panel ii) . ASC probes from sheep killed 14 days after a primary infection showed strong and restricted reactivity on immunoblots to whole-cell antigens (Fig. lb) , especially compared with serum antibody. Probes from ASC draining the infected site were strongly reactive, while those from the contralateral uninfected site showed background reactivity to the 28-kDa protein (Fig. lb) .
The spectrum of reactivity of ASC probes at day 14 to antigens of C. pseudotuberculosis showed some variation between sheep, with a number of bands highlighted by some sheep (Fig. lb, panels iii and iv) . However, a 40-kDa antigen was consistently and strongly recognized on immunoblots and in two sheep was the major antigen recognized (Fig. lb, panels ii and iii). Analysis of immunoblots of sera showed that infected sheep also had circulating antibody to the 40-kDa antigen, and sequential serum samples showed this was one of the earliest antigens recognized during the course of infection (Fig. la, panel ii) . ASC probes also strongly recognized the 40-kDa antigen in concentrated culture supernatant (Fig. 2b) , with a minor band at 38 kDa also visible, which we believe to be a smaller form of the same antigen. Polyclonal sera raised to the 40-kDa antigen preparation also recognized the 38-kDa band, seen in Fig. 2c as the lower band of a doublet.
ELISA of antibodies in scrum taken at day 14 and in ASC probes from the same sheep to whole-cell and supernatant antigens of C. pseudotuberculosis confirmed the results obtained from the immunoblots (Tables 1 and 2 ). Antibody (Fig. 2a, lane 3) ; this is defined as the 40-kDa antigen preparation. The major contaminating moieties were peptides of less than 20 kDa derived from the culture medium. The large scale precluded some techniques, such as gel chromatography, for further purification. Silver staining highlighted a red-to-rust brown diffuse band at the top of the gel. The 31-kDa PLD toxin was the major protein present in bacterial culture supernatants (Fig. 2a, lane 2) but could not be detected either on stained gels of the 40-kDa antigen preparation or on immunoblots of sera from sheep immunized with the 40-kDa antigen preparation; such blots showed that only the 40-kDa antigen was immunogenic (Fig. 2c) . The contaminating bands of <20 kDa visible in Fig. 2a, lane 3, were not immunogenic when reacted with ASC probes (Fig. 2b) or with the sheep sera (Fig. 2c) . Six field isolates of C. pseudotuberculosis were shown by immunoblotting experiments using ASC probes to also contain the 40-kDa antigen (not shown).
Immune response to vaccination. Antibody titers of vacci- Unvaccinated control sheep had significantly lower titers (OD450 ± standard deviation = 0.075 + 0.122). Immunoblots of sera from vaccinated sheep showed a strong response only to the 40-kDa antigen (Fig. 2c) .
Lesion scores. Infectious challenge with C. pseudotuberculosis in the right hock 3 months prior to slaughter resulted in a satisfactory level of infection, with 55% of control animals developing lesions (Table 3) .
Vaccination with 100-[wg doses of the 40-kDa antigen preparation had a major effect on development of disease and significantly reduced the infection rate from 55 to 5% (z test value = 3.58, P < 0.002). Vaccination with 5-pLg doses of antigen resulted in a small and insignificant reduction in the infection rate to 41% (z test value = 1.25, P < 0.20).
Lung lesion scores provided the best measure of protection achieved by vaccination with the 40-kDa antigen preparation. More control sheep developed lung lesions than developed lesions in lymph nodes, and those infected often had multiple lesions in the lung (Table 3) . Of the nine control sheep with lung lesions, five did not have lesions in popliteal or other lymph nodes.
Vaccination with 100-pLg doses of the 40-kDa antigen preparation gave a significant 98% reduction in the incidence of lung lesions (unpaired t test, t = 2.046, 41 df, P < 0.025; Table   3 ). The 5-pLg dose sheep showed a 79% reduction (t = 1.932, 42 df, P < 0.05). Vaccination also tended to reduce the lesion size, with control group lesions having an average diameter of 67 mm and lesions in the 5-and 100-p.g dose groups having average diameters of 37 and 26 mm, respectively. These data show that in addition to preventing actual infection as reflected in the number of lung lesions, vaccination with the 40-kDa antigen preparation also limited the development of established foci of infection.
The right popliteal lymph node drains the site of infectious challenge; however, only 5 of the 22 right popliteal lymph nodes from control sheep showed lesion development. Vaccination of sheep with the 40-kDa antigen preparation at 5-and 100-,ug dose levels prevented infection in the right popliteal lymph node ( Antibody probes produced by ASC taken from the lymph nodes draining the site of infection with C. pseudotuberculosis showed restricted antigenic reactivity on immunoblots, particularly compared with the diverse spectrum of antigens identified by antibodies from serum present in the sheep at the time of sampling of lymph nodes. This restricted response identified a novel 40-kDa antigen from C. pseudotuberculosis. The kinetics of the serum immune response of naive sheep also highlighted the 40-kDa antigen as one of the predominant antigens recognized (Fig. la) at day 7 postinfection. By day 14, when ASC from lymph nodes were obtained, the serum response was heterogeneous and the 40-kDa antigen response was no longer obvious over other antigens on immunoblots. Taken together, the restricted response of ASC probes and the more heterogeneous response in serum show that the greater part of serum antibody to an infectious challenge is not being synthesized in the draining lymph nodes. The pool of antibodies in serum specific for antigens other than the 40-kDa antigen are presumably being synthesized in other lymphoid tissues, like the spleen.
Vaccination of sheep with 100 ,ug of the 40-kDa antigen preparation gave up to 82% reduction in the proportion of infected sheep. This level of protection compares favorably with the levels of protection achieved with currently available commercial vaccines (5, 7) . The lower dose level of 5 ,ug of 40-kDa antigen preparation did not provide a significant level of protection in terms of infected sheep but did significantly reduce the incidence of lung lesions. This lower level of protection was not reflected in lower group mean titers of antibody, with group means of the 5-and 100-,ug dose groups not being significantly different. In addition, there was no discernible relationship between lung lesion scores and antibody titers. These data strongly implicate cellular immunity as the primary mechanism of immune rejection of infection.
Immunoblot analysis of sera from sheep vaccinated with the 40-kDa antigen preparation showed a strong antibody response restricted to the 40-kDa protein (Fig. 2c) . The lowermolecular-mass components of approximately 20 and less than 15 kDa in the 40-kDa antigen preparation were not immunogenic. These were assumed to be derived from medium components of bovine origin. There was no response detected to the 31-kDa PLD toxin. We have not analyzed the cellular immune response to vaccination. The significant protection achieved by vaccination suggests that the 40-kDa antigen plays a major role in protection against CLA. To date, the only other recognized protective antigen has been PLD, which is also a major determinant of virulence (5, 13, 14, 17 Studies of serum antibody responses following natural infection and vaccination have highlighted a wide range of antigens from C. pseudotuberculosis (8, 9) . These previous studies showed a number of antigens in the 40-kDa region on immunoblots, but the strong response to a very wide range of antigens prevented the selection of any particular antigen as being important in immunity. Identification of protective antigens by immunoscreening using serum antibodies has yielded important candidate vaccine antigens, for example, paramyosin of Schistosoma mansoni (18) . In previous studies of CLA (9) and in mycobacterial infections, which like CLA are caused by facultative intracellular pathogens, effective vaccine antigens have not yet been identified. We have shown here that ASC probes generated by ASC taken from lymph nodes draining the site of a challenge infection with C. pseudotuberculosis identified a highly protective antigen. This study demonstrates that generation of ASC probes from a site of infection provides a rational approach to the identification of candidate vaccine antigens which may have application to a wide range of diseases of both humans and animals.
